Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-01-30
1982-06-01
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, G01N 3356, G01T 100, G01N 3360
Patent
active
043327842
ABSTRACT:
Dual isotope assays for thyroid function are performed by carrying out a radio-immunoassay for two of thyroxine (T4), tri-iodothyronine (T3), thyroid stimulating hormone (TSH), and thyroxine binding globulin (TBG) wherein a version of one of the thyroid components, preferably T4 or T3 is labelled with Selenium-75 and the version of the other thyroid component is labelled with a different radionuclide, preferably Iodine-125.
REFERENCES:
patent: 3952091 (1976-04-01), Grunberg et al.
patent: 4016250 (1977-04-01), Saxena
patent: 4115065 (1978-09-01), Bayly et al.
patent: 4225576 (1980-09-01), Denning et al.
Brown et al.; J. Nucl. Med., 18, #3, 300-304, 1977.
Girgis et al.; Nuclear Science Abstracts, vol. 26, #3, Feb. 15, 1972, Abstract 4672.
Mitsuma et al.; Biochem. Biophys. Res. Comm., vol. 46, #6, 2107-2113, 1972.
Jacoby Benjamin
Smith Geoffrey F. W.
Stevens Ralph A. J.
Nucker Christine M.
The Radiochemical Centre Limited
LandOfFree
Dual isotope assays does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dual isotope assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual isotope assays will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849388